Recent developments highlight Spok's Q3 2026 financial results, dividend declarations, and operational updates from earnings calls.

• Spok Holdings, Inc. reported third quarter 2026 net income of $9.7 million and declared a quarterly dividend of $0.3125 per share [N1].
• The company held Q2 2026 earnings calls providing detailed operational and financial insights [N2,N3].
• Spok's Q2 2026 earnings and revenues surpassed prior period levels [N4].
• The company missed Q1 2026 earnings and revenue estimates [N5].

Spok's diversified revenue streams from wireless messaging and software solutions provide resilience. The company's focus on healthcare and critical communication sectors supports steady demand. Recent operational improvements and dividend declarations indicate financial discipline and shareholder returns. The company's lease portfolio and transmitter network underpin service delivery capabilities.

Spok faces risks from technological changes that could disrupt traditional paging and messaging services. Dependence on leased facilities and transmitter sites exposes the company to lease renewal and cost risks. Competitive pressures from alternative communication platforms and potential regulatory changes could impact revenue. The company's exposure to a concentrated geographic market (primarily the U.S.) may limit growth opportunities.

Spok's moat is based on its specialized clinical communication solutions tailored for healthcare and other critical sectors, supported by a broad network of leased transmitter sites and established customer relationships. Its integrated software and wireless messaging services create switching costs for customers seeking unified communication platforms. The company's regulatory compliance, industry-specific expertise, and ongoing service contracts contribute to customer retention and competitive positioning.

• Technological Disruption: Emerging communication technologies may reduce demand for traditional paging and messaging services, impacting wireless revenue.
• Lease and Infrastructure Risks: Dependence on leased transmitter sites and facilities exposes the company to lease renewal risks and potential cost increases.
• Market Concentration: Primary revenue generation in the United States may limit diversification and expose the company to regional economic or regulatory changes.
• Competitive Pressure: Competition from alternative communication and collaboration platforms could erode market share and pricing power.

• Spok Holdings, Inc is a clinical communication and collaboration company primarily serving the healthcare industry, especially hospitals, but also government agencies, public safety institutions, colleges, hotels, resorts, casinos, and manufacturers [S1].
• The company offers unified clinical communication solutions including call center applications, clinical alerting and notifications, one-way and two-way wireless messaging services, mobile communications, and public safety solutions [S1].
• Revenue is generated from wireless messaging services (paging, voice mail, message storage, equipment, maintenance) and software solutions (licenses, hardware sales, professional services, maintenance, and subscriptions) [S1,S2].
• Wireless revenue includes paging revenue and product/other revenue; software revenue includes license, professional services (projects and managed), hardware, and maintenance/subscription revenue [S1,S2].
• Spok's software licenses are generally right-to-use licenses with standalone functionality, recognized at a point in time; wireless, professional services, and maintenance revenues are recognized over time based on performance progress [S2].
• The company operates as a single reportable segment focused on clinical communication and collaboration, with the United States as the primary geographic market [S2].
• As of September 30, 2026, Spok had 20,918,137 shares of common stock outstanding and no preferred stock outstanding [S2].
• Spok declared a quarterly cash dividend of $0.3125 per share in October 2026, with total dividends declared in 2026 amounting to approximately $20.5 million [S1,S2].
• The company had cash and cash equivalents of approximately $30.1 million and current assets of $57.2 million as of September 30, 2026, with current liabilities of $44.3 million, resulting in a current ratio of 1.29 and a cash ratio of 0.68 [S2].
• Net income for the third quarter ended September 30, 2026 was $9.7 million with basic and diluted EPS of $0.46 [S2,N1].
• Total revenue for the nine months ended September 30, 2026 was approximately $101.2 million, with wireless revenue of $51.7 million and software revenue of $49.5 million [S2].
• Operating expenses include cost of revenue, research and development, technology operations, selling and marketing, general and administrative, severance and restructuring, and depreciation and accretion [S1].
• The company leases approximately 50,000 square feet of facility space across 36 locations in 23 U.S. states and leases transmitter sites at about 2,379 locations with 2,869 active transmitters as of December 31, 2025 [S1].
• Spok has a share repurchase program authorized for up to $10 million but did not repurchase shares in the nine months ended September 30, 2026 [S2].
• Deferred revenue was $31.6 million as of September 30, 2026, with remaining performance obligations of $52.0 million excluding cancellable amounts [S2].
• The company recognized a $7.5 million gain from the sale of narrowband spectrum licenses during the nine months ended September 30, 2026 [S2].
• Spok monitors goodwill quarterly and performed a qualitative assessment in Q3 2026 with no triggering event for impairment identified [S2].
• The company has asset retirement obligations related to transmitter locations totaling $5.6 million as of September 30, 2026 [S2].
• Recent news highlights include Q3 2026 net income of $9.7 million and declaration of quarterly dividend of $0.3125 per share [N1].
• Q2 2026 earnings call and highlights indicate operational updates and financial results [N2,N3,N4].
• The company missed Q1 2026 earnings and revenue estimates [N5].